Abstract
The PI3K/Akt/mTOR (PAM) axis is constitutively activated in multiple lymphoma subtypes and is a promising therapeutic target. The mTOR inhibitor temsi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
